We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01635686
Recruitment Status : Unknown
Verified July 2012 by Daewoong Pharmaceutical Co. LTD..
Recruitment status was:  Not yet recruiting
First Posted : July 9, 2012
Last Update Posted : July 26, 2012
Sponsor:
Information provided by (Responsible Party):
Daewoong Pharmaceutical Co. LTD.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2013
  Estimated Study Completion Date : June 2013